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DRUG-RESISTANT 
TUBERCULOSIS (TB) 
THREAT LEVEL SERIOUS
847
Cases  
in 2017
62
Deaths  
in 2017
$164,000
Per MDR case
$526,000
Per XDR case
TB is caused by Mycobacterium tuberculosis, bacteria that usually attack the lungs. Drug-resistant TB 
develops when the antibiotics used to treat TB are misused or mismanaged, and it can spread.
WHAT YOU NEED TO KNOW
 ■ TB spreads from person to person through the air. It is 
one of the world’s most deadly infectious diseases. 
 ■ In most cases, TB is curable; however, people with TB 
can die without proper treatment. Treatment for drug-
resistant TB is costly, lengthy, disrupts lives, and can 
have life-threatening side effects. 
 ■ MDR TB is resistant to two first-line antibiotics. XDR TB 
is resistant to some first- and second-line antibiotics. 
 ■ The number of drug-resistant TB cases in the United 
States remain stable due to effective control strategies.
Data represents U.S. cases only. MDR: multidrug-resistant. XDR: extensively  
drug-resistant.
CASES OVER TIME
TB is most commonly resistant to isoniazid, one of the first-line 
TB antibiotics (called INH resistance).
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DRUG-RESISTANT TUBERCULOSIS 
TOXIC SIDE EFFECTS  
FROM TB TREATMENT
Dr. Dalene von Delft was a newly  
qualified doctor in South Africa when 
her dreams of becoming a pediatric 
surgeon were shattered. Dalene 
contracted MDR TB. Treatment took  
19 harrowing months. 
Dalene had to inject toxic second-line antibiotics that 
can cause severe side effects. She took 30 pills a day— 
24 for TB and six for the side effects of TB treatment. 
The treatment made her so ill that she started to go deaf. 
Dalene had to make potentially life-threatening decisions 
to stop treatment to preserve her hearing and career. 
She often listened to music, worried the songs would be 
the last she ever heard. 
MDR TB affects people in the United States and around 
the world. Dalene recovered due to a new treatment that 
was in development. She founded a campaign to help 
protect healthcare workers and medical students against 
work hazards. CDC continues to work to stop the spread 
of TB and protect the health of all people.
TYPES OF RESISTANCE
TB treatment requires four first-line antibiotics: rifampin, 
isoniazid, pyrazinamide, and ethambutol. When TB becomes 
resistant to any of these drugs, it limits treatment options and 
puts the patient at risk for untreatable TB.
DRUG-RESISTANT TB
Resistant to 1 of 4 first-line antibiotics used to 
treat TB. The most common is INH-resistant TB, 
which is resistant to isoniazid.
MDR TB
Resistant to 2 of 4 first-line antibiotics, isoniazid 
and rifampin—the most potent drugs to treat TB.
XDR TB
Rare type of MDR TB that is also resistant to at 
least 1 of the 3 second-line antibiotics, including 
fluoroquinolones. Second-line antibiotics can be 
toxic and cause severe side effects. 
First-line antibiotics Second-line antibiotics
ONLINE RESOURCES
About Drug-resistant TB
www.cdc.gov/TB/Topic/DRTB
TB Personal Stories 
www.cdc.gov/TB/Topic/Basics/PersonalStories.htm
This fact sheet is part of CDC’s 2019 Antibiotic Resistance Threats Report.  
The full report, including data sources, is available at www.cdc.gov/DrugResistance/Biggest-Threats.html.
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